Trial
NCT03576885
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
AdventHealth
Collaborators
Mallinckrodt; Thrasher Research Fund
Condition
Pulmonary Hypertension
Intervention
inhaled nitric oxide
Why stopped
based on DSMB recommendation at interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-15